Pomegranate Extract Improves Maximal Performance of Trained Cyclists after an Exhausting Endurance Trial: A Randomised Controlled Trial.
Antonio Torregrosa-GarcíaVicente Ávila-GandíaAntonio J Luque-RubiaMaría Salud Abellán-RuizMaría Querol-CalderónFrancisco Javier López RománPublished in: Nutrients (2019)
The efficacy of pomegranate (Punica granatum) extract (PE) for improving performance and post-exercise recovery in an active population was equivocal in previous studies. In this study, a randomised, double-blinded, placebo-controlled, balanced, cross-over trial with two arms was conducted. Eligibility criteria for participants were as follows: male, amateur cyclist, with a training routine of 2 to 4 sessions per week (at least one hour per session). The cyclists (n = 26) were divided into treatment (PE) and placebo (PLA) groups for a period of 15 days. After physical tests, the groups were exchanged after a 14-day washout period. Exercise tests consisted of endurance bouts (square-wave endurance exercise test followed by an incremental exercise test to exhaustion) and an eccentric exercise drill. The objective was to assess the efficacy of PE in performance outcomes and post-exercise muscular recovery and force restoration after a prolonged submaximal effort. Twenty-six participants were included for statistical analysis. There was a statistically significant difference in total time to exhaustion (TTE)(17.66⁻170.94 s, p < 0.02) and the time to reach ventilatory threshold 2 (VT2)(26.98⁻82.55 s, p < 0.001), with greater values for the PE compared to the PLA group. No significant results were obtained for force restoration in the isokinetic unilateral low limb test. PE, after a prolonged submaximal effort, may be effective in improving performance outcomes at maximal effort and might help to restore force in the damaged muscles.
Keyphrases
- resistance training
- high intensity
- body composition
- physical activity
- study protocol
- clinical trial
- placebo controlled
- phase iii
- double blind
- skeletal muscle
- single molecule
- mental health
- squamous cell carcinoma
- open label
- blood pressure
- phase ii
- metabolic syndrome
- randomized controlled trial
- type diabetes
- radiation therapy
- clinical practice
- anti inflammatory